If you have hereditary ATTR amyloidosis, there's a 50% chance of passing it to your children.
The HSE have reversed a decision not to reimburse people for a drug for those with a rare condition that causes nerve damage.
Hereditary ATTR amyloidosis, has a specific Irish variant and can be passed on genetically.
Amvuttra is a new treatment that would only need to be administered 4 times a year, rather than the 17 times required currently.
Last year, the Health Service decided the drug would not be reimbursed, however, that decision has been reversed subject to a managed access protocol.
Fianna Fáil Longford Westmeath TD, Joe Flaherty says it's an important move:
Two Offaly Women Selected For National Nature Restoration Portrait Series
Westmeath Town Band Opens Recruitment To New Members
Laois Disability Centre Fails HIQA Inspection In Four Regulation Areas
Offaly Community Group Aims To Support Young People’s Physical And Mental Health
New Brian Cowen Biography To Be Launched In Offaly Tonight
Midlands Homelessness Figures Record Slight Monthly Increase
Credit Union Lending Surges As Mortgage Growth Continues Amid Merger Wave
37% Of People Aged 25 To 64 In The Midlands Leave School Without Third-Level Education